Lo Re Research Group

Header Image

News

In the News

Penn Medicine News Releases:

New Approach Accurately Identifies Medications Most Toxic to the Liver (June 25, 2024)
People with Severe COVID-19 Face Increased Risk of Life-Threatening Blood Clots (August 16, 2022)
Penn Medicine study suggests long-term suppression of hepatitis B in patients who are HIV-coinfected may lower cancer risk (May 21, 2021)
Half of Hepatitis C Patients with Private Insurance Denied Life-Saving Drugs (June 7, 2018)
Vincent Lo Re, MD, Receives the 2016 HIV Medicine Association Research Award for Outstanding Contributions to Clinical Care and Research (October 27, 2016)
Penn Medicine Researcher Receives $3 million NCI Grant to Study Links between Liver Cancer and HIV (April 21, 2016)
Nearly Half of Hepatitis C Patients on Medicaid Denied Coverage for Life-Saving Drugs, Penn Researchers Report (November 16, 2015)
Prescription Drug-Induced Liver Failure is Uncommon; Over-the-Counter Medications and Dietary/Herbal Supplements are Most Common Causes, Penn Study Finds (March 3, 2015)
Major Gaps in Hepatitis C Care Identified As New Drugs and Screening Efforts Emerge, Penn Study Finds (July 2, 2014)
Penn Study: Hepatitis C Remains Major Problem for HIV Patients Despite Antiretroviral Therapy (March 17, 2014)
Hepatitis C Patients Likely to Falter In Adherence to Treatment Regimen Over Time, Penn Study Shows (September 30, 2011)

Selected News Mentioning Our Research:

2024

Q&A: Panel offers actionable steps toward hepatitis C elimination — Physicians Weekly (September 23, 2024)
Most potentially hepatotoxic meds revealed: real-world data analysis — Medscape (July 16, 2024)
New approach uses real-world data to identify the most potentially hepatotoxic medications — Healio (June 27, 2024)
Real-world analysis identifies meds tied to higher risk of liver injury — MedPage Today (June 25, 2024)
17 drugs most potentially toxic to the liver identified: UPenn study — The Epoch Times (June 24, 2024)
Is your liver at risk from common medications? — The Daily Gazette (June 24, 2024)

2023

IDSA, AASLD hepatitis C guidelines offer strategies for incomplete adherence — Contagion Live (June 4, 2023)
Symptom scoring framework paves the way for long COVID definition — Contagion Live (May 31, 2023)
Keeping up with changes in HCV guidance: An update on the latest recommendations — Infectious Diseases Society of America (May 30, 2023)
12 key symptoms define long COVID, new study shows, bringing treatments closer — WSILTV (May 25, 2023)
Update in hepatitis C — Penn Medicine Podcast (January 13, 2023)

2022

Higher Risk of Venous Thromboembolism in Hospitalization for COVID-19 Than Influenza — NeurologyLive (September 12, 2022)
Thromboembolism After COVID-19 vs Influenza — Contagion Live (August 29, 2022)
Hospitalization due to COVID-19 increases risk of venous thromboembolism compared to hospitalization due to influenza — 2 Minute Medicine (August 21, 2022)
VTE Risk Higher With COVID-19 Than With Flu — TCTMD (August 18, 2022)
Higher risk of vein blood clots in COVID vs flu patients — Center for Infectious Disease Research & Policy (August 16, 2022)
Risk for VTE higher with COVID-19 than influenza — Healio (August 16, 2022)

2021

People with both HIV and detectable hepatitis B are at higher risk for liver cancer — Hep Magazine (June 16, 2021)
HBV suppression lowers liver cancer rates in patients coinfected with HIV — Clinical Advisor (June 11, 2021)
Treating hepatitis B in HIV patients can reduce risk of primary liver cancer, Penn Medicine study finds — The Daily Pennsylvanian (May 26, 2021)

2020

Vincent Lo Re, MD, MSCE, on Overcoming the Barriers to Hepatitis C Virus Cure — Consultant 360 Specialty Network (November 9, 2020)
Vincent Lo Re, MD, MSCE, on the Challenges of Managing Hepatitis C Virus — Consultant 360 Specialty Network (November 9, 2020)
Vincent Lo Re, MD, MSCE, on the Challenges of Diagnosing Hepatitis C Virus — Consultant 360 Specialty Network (November 9, 2020)
Stigma and Its Determinants Among Individuals With Hepatitis C Virus Infection — Infectious Disease Advisor (June 24, 2020)

2019

HCC with no cirrhosis is more common in HIV patients — MD Edge Hematology/Oncology (March 14, 2019)
Higher HIV viral load and lower CD4 count linked to liver cancer risk — NAM AIDS Map (March 13, 2019)
Detectable HIV and Lower CD4 Count Raise Liver Cancer Risk — POZ (March 11, 2019)
Liver Cancer Linked to Detectable HIV and Lower CD4 Count — Cancer Health (March 11, 2019)

2018

High Cost of Hepatitis C Drugs Leads to Lengthy Battles for Access to Therapies — MD Magazine (August 29, 2018)
Everything You Need to Know About Hepatitis A, B, C, D, and E — Healthline (August 3, 2018)
One-Third of Chronic HCV Patients Get Denied Direct-Acting Antiviral Therapy — MD Magazine (June 16, 2018)
Private Payers Deny Hepatitis C Drug Coverage to 52% of Members — Health Payer Intelligence (June 13, 2018)
Private insurers deny drug coverage for half of hepatitis C patients — WHYY (June 8, 2018)
Insurers Continue to Deny Coverage for Life-Saving Hepatitis C Drugs at High Rates — Specialty Pharmacy Times (June 8, 2018)
Over One-Third of HCV Patients Denied DAA Tx by Payers — MedPage Today (June 7, 2018)
One-third of hepatitis C prescriptions rejected by insurers, study says — United Press International [UPI] (June 7, 2018)
There's a Cure for Hepatitis C, but Insurance Companies Don't Want to Pay for It — Gizmodo (June 7, 2018)
Insurance denials for HCV therapy increase in the US — Healio (June 7, 2018)
One-third of Patients Denied New Hepatitis C Drugs — Medscape (June 7, 2018)
Insurer denials for Hepatitis C treatment remain high — Modern Healthcare (June 7, 2018)
Despite their efficacy, life-saving drug prescriptions are denied by insurers — Penn Today (June 7, 2018)
Insurance denials for new hepatitis C drugs remain high nationwide, study suggests — Infectious Diseases Society of America (IDSA) News Release (June 7, 2018)
Hepatitis C patients routinely denied drugs in 45 states, a Penn study shows — Philadelphia Inquirer (June 6, 2018)
The Lo Re Research Group: Bringing new data to the forefront of HCV — Healio HCV Central (April 2, 2018)
Taking multiple Rx drugs raises risks for aging adults with and without HIV — Yale News (January 30, 2018)

2017

HIV/HCV Coinfection Remains Marginalized Despite Progress — Healio HCV Next (September/October 2017)
Hepatitis C Virus Infection and Cardiovascular Disease Risk — Infectious Disease Advisor (August 14, 2017)
Facing the Challenges of Universal Screening for HCV — Healio HCV Next (July/August 2017)
Hepatitis C Virus (HCV): What You Need to Know to Screen and Treat Your Patients — ReachMD (May 8, 2017)

2016

[VIDEO] Patients with HIV, HCV face risk for re-infection following antiviral treatment — Infectious Disease News (May 27, 2016)
Diplomat's Hepatitis C Coverage Study with Penn Medicine Published and Chosen as Top Editor's Pick — PR Newswire (May 18, 2016)
Get tested — Pocono Record (May 18, 2016)
Are States Obligated to Provide Expensive Hepatitis C Drugs? — Stateline (February 9, 2016)

2015

Hepatitis C Patients on Medicaid Often Denied Coverage for New Effective Drugs — Hepatitis News Today (December 8, 2015)
Hepatitis C Meds and Medicaid: Take These Steps to Get Covered — Everyday Health (December 4, 2015)
Half of Hepatitis C Patients on Medicaid Denied Drug Access — Specialty Pharmacy Times (November 20, 2015)
Medicaid Denies Nearly Half Of Hep C Drug Requests — WebMD (November 20, 2015)
Medicaid Denies Nearly Half Of Requests For Hepatitis C Drugs: Study — Kaiser Health News (November 20, 2015)
Medicaid patients with HCV more often denied DAA therapy — Healio (November 19, 2015)
Medicaid Denial for Hep C Drugs Nearing 50% in Some States — Medscape (November 18, 2015)
Almost half of US Medicaid recipients denied funding for hepatitis C treatment, 4-state study shows — AIDS Map (November 17, 2015)
[VIDEO] Q&A with the University of Pennsylvania's Vincent Lo Re, MD: Managing Denials of Hepatitis C Prescriptions — MD Magazine (November 17, 2015)
Insurance Lagging on Paying for HCV Antivirals — MD Magazine (November 14, 2015)
Medicaid denies half of prescriptions for new hepatitis C drugs, Penn study finds — Philadelphia Inquirer (November 14, 2015)
Pennsylvania's Medicaid eases restrictions on hepatitis C treatment — WHYY/Newsworks (August 17, 2015)
Over-the-counter meds, supplements may cause acute liver failure — Healio (March 10, 2015)
OTC medications, dietary and herbal supplements cause drug-induced acute liver failure — News Medical (March 4, 2015)

2014

5 Things You Need to Know About Ebola — Men's Journal (October 17, 2014)
Drug cocktails point the way towards relief for all hepatitis C sufferers — Financial Times (July 27, 2014)
Patients with chronic HCV at increased risk for low muscle mass — Healio (July 17, 2014)
Studies Look at Hepatitis C Care Cascade and Healthcare Utilization — HIV and Hepatitis (July 3, 2014)
Only 10% With Chronic Hepatitis C Complete Successful Treatment — News@JAMA (July 2, 2014)
Alcohol Consumption Too Risky For Advanced Liver Disease In HIV/Hep C Patients — Counsel & Heal (May 3, 2014)
HIV Coinfection Ups Hepatic Decompensation in HCV Patients — Medscape (April 14, 2014)
Hepatitis C Patients With HIV May Face Higher Risk of Liver Disease — WebMD (March 19, 2014)
[VIDEO] Additional insights into article, "Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hep C Virus Compared With Hep C Virus-Monoinfected Patients. A Cohort Study." — Annals of Internal Medicine (March 18, 2014)
Those With HIV And Hepatitis C Have 80 Percent Higher Risk Of Liver Disease — Headlines & Global News (March 19, 2014)

2012

Patients Coinfected With HIV and HCV More Likely to Experience Severe Worsening of Liver Disease — News@JAMA (July 26, 2012)

2008

Liver Enzyme Elevations in HIV Positive Individuals with Occult Hepatitis B Virus Infection — HIV and Hepatitis (October 17, 2008)